Patents for A61P 33 - Antiparasitic agents (21,787)
03/2004
03/04/2004US20040044074 Pharmaceutical composition containing aminoacetonitril compounds and the use thereof for the preparation of a pharmaceutical composition for the treatment of endoparasitic pests in animals
03/04/2004US20040044055 N-alkoxlyalkyl-substituted benzimidazoles and the use thereof as an agent against parastic protozoans
03/04/2004US20040043962 Method for enhancing the effectiveness of cancer therapies
03/04/2004US20040043945 Crystal forms of azithromycin
03/04/2004US20040043944 Form of azithromycin selected from the group consisting of forms D, E, substantially pure F, G, J, M substantially in the absence of azithromycin dihydrate, N, O, P, Q, and R; NMR spectrun analysis; bactericides; antiprotozoa agents; infections of mammals, birtds, and fish; drug resistance
03/04/2004US20040043925 Cyclic depsipeptides; veterinary medicine
03/04/2004CA2494974A1 Il-7 drug substance, composition, preparation and uses
03/03/2004EP1392852A2 Nucleic acid-associated proteins
03/03/2004EP1392844A2 Use of hmg fragments as anti-inflammatory agents
03/03/2004EP1392642A2 Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents
03/03/2004EP1392351A2 Chemokines as adjuvants of immune response
03/03/2004EP1392332A1 Method for the destruction of oocysts
03/03/2004EP1392317A2 Substituted 1-benzazepines and derivatives thereof
03/03/2004EP1392290A1 Use of certain substituted pyrrolidones such as piracetam in the treatment of viral and other diseases
03/03/2004EP1392281A2 Anti-endoparasitic amidoacetonitrils
03/03/2004EP1131331B1 13-membered azalides and their use as antibiotic agents
03/03/2004EP0859628B9 Drug, in particular for modulating the immunological response for the control of viruses, tumours, bacteria and parasites
03/03/2004EP0613375B1 Pharmaceutical lysine-containing polypeptide compositions and the use thereof
03/03/2004CN1479739A Heterocyclic ether substituted imidazoquinolie compounds
03/03/2004CN1479738A Thioether subsituted imidazoquinoline compound
03/03/2004CN1479725A N-alkoxyalkyl-substituted benzimidazoles and use thereof as active agent aginst parasitic protozoans
03/02/2004US6699887 Administering a therapeutically effective amount of a pyrrazole sulfide or ether compound to treat the human immunodeficiency virus infection
03/02/2004US6699878 Imidazonaphthyridines
03/02/2004US6699854 2-substituted 4-heteroaryl- pyrimidines, inhibitors of cyclin-dependent kinases (cdks)
03/02/2004US6699847 Antiparasitic formulation
03/02/2004US6699678 Chlamydia trachomatis specific peptides and their use in diagnostic assays
02/2004
02/26/2004WO2004016588A1 Furanone derivatives and methods of making same
02/26/2004WO2004016261A1 Method for suppressing proliferation of abnormal prion protein with leucine, isoleucine or valine
02/26/2004WO2003103584A3 Ether substituted imidazopyridines
02/26/2004WO2003040144A3 Heterocyclic compound based on n6-substituted adenine, methods of their preparation, their use for preparation of drugs, cosmetic preparations and growth regulators, pharmaceutical preparations, cosmetic preparations and growth regulators containing these compounds
02/26/2004WO2003006425A9 Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents
02/26/2004WO2002103002A3 Gene associated with leishmania parasite virulence
02/26/2004WO2001057175A3 Methods and materials relating to neurotrimin-like polypeptides and polynucleotides
02/26/2004US20040039061 Suppress expression and induction of inflammatory cytokines, cell adhesion molecule gene and virus and suppressors for nuclear factor kappa beta (nf-kb)
02/26/2004US20040039008 Peroxy compounds such as adamantane-2-spiro-3'-8'-((1'S)-10'-camphorsulfonyl)-1',2',4'-trioxa-8' -azaspiro(4.5)decane, used for prophylaxis of malaria or schistosomiasis infections
02/26/2004US20040039001 2-guanidino-4-aryl-quinazoline
02/26/2004US20040038957 Anti-malarial activity
02/26/2004US20040038941 Compounds for the treatment of inflammatory disorders
02/26/2004US20040038933 Pharmaceutical compositions, dose and method for treating malaria
02/26/2004US20040038879 For therapy and prophylaxis of infections such as bacterial, fungal, protozoan, and viral infections, particularly those caused by HIV viruses, pain, cancers, anorexia, bulimia, asthma, Parkinson's disease, acute heart failure
02/26/2004US20040038339 Multifunctional polypeptides comprising a binding site to an epitope of the nkg2d receptor complex
02/26/2004US20040038235 A g-protein coupled receptor
02/26/2004US20040037854 Oral vaccines to prevent candida infection
02/26/2004US20040037838 Polypeptide with the amino acid sequence of the C-terminal part of the circumsporozoite protein of a plasmodium in which cysteine residues are oxidized along with carriers, adjuvants and biodegradable microcapsules
02/26/2004CA2495784A1 Furanone derivatives and methods of making same
02/25/2004EP1391513A1 IL-7 drug substance, IL-7 comprising composition, preparation and uses thereof
02/25/2004EP1390403A2 Peptides derived from neural thread proteins and their medical use
02/25/2004EP1390401A2 Plasmodium falciparum antigens and vaccine and diagnostic uses thereof
02/25/2004EP1390391A1 Transporters and ion channels
02/25/2004EP1390377A1 Crystal forms of azithromycin
02/25/2004EP1390348A1 5-cyano-1h-indole derivatives as antagonists of the interleukine-8 receptors
02/25/2004EP1390344A2 Organic compounds
02/25/2004EP1263756B1 Beta-amino acid derivatives as inhibitors of matrix metalloproteases and tnf-alpha
02/25/2004EP1049378B1 An antimicrobial composition
02/25/2004EP1037609B1 Aqueous insecticidal pour-on formulation
02/25/2004EP0918756B1 Parasiticidal pyrazoles
02/25/2004CN1478084A Compounds useful in treatment of inflammatory diseases
02/25/2004CN1478081A Substituted 2-znilino-benzimidazoles and use thereof as NHE-inhibitors
02/25/2004CN1476895A Avermectin or ivermectin and sheep clostridial disease vacine mixed preparation
02/25/2004CN1476875A Chinese herbal medicine mixture for preparing medicine with functions of expelling intestinal worms, removing food stagnancy and promoting digestion for domestic animals
02/25/2004CN1139592C Camptothecin derivatives its preparing and use and midbody
02/24/2004US6696458 Having x-ray powder diffraction pattern with lines at degrees 2 theta values 6.7, 12.5, 14.0 and 23.9 for cu k alpha radiation of wavelength 1.5406 angstrom
02/24/2004US6696455 Nitrogen compounds such as 6-chloro-2-methyl-4-oxo-pyrido (3,2-d)pyrimidine used as anticarcinogenic agents and/or for prophylaxis of infections caused by pneumocystis or toxoplasma
02/24/2004US6696268 Production and use of antimicrobial agents
02/24/2004CA2315067C Aqueous insecticidal pour-on formulation
02/19/2004WO2004015122A1 Method for reproducing pleuromutilins
02/19/2004WO2004014920A1 Bicyclic heteroaromatic compounds as kinase inhibitors
02/19/2004WO2004014903A1 2-(3-aminoaryl)amino-4-aryl-thiazoles and their use as c-kit inhibitors
02/19/2004WO2004014408A1 Intravaginal washing agent
02/19/2004WO2004014304A2 Electrospun amorphous pharmaceutical compositions
02/19/2004WO2004014146A1 The use of fermented wheat-germ in the feeding and veterinary practice
02/19/2004WO2004007478A3 Derivatives of 3-guanidinocarbonyl-1-heteroaryl-pyrrole, process for their preparation and their pharmaceutical use
02/19/2004WO2004000793A3 Aminoacetonitrile derivatives suitable for controlling parasites
02/19/2004WO2003101995A3 Camptothecins with a modified lactone ring
02/19/2004WO2002048337A3 Secreted human proteins
02/19/2004US20040034218 Farnesyl transferase inhibiting benzoheterocyclic derivatives
02/19/2004US20040034103 Cdc25 photophatase inhibitors
02/19/2004US20040034090 Such as (7-chloro-2-methyl-1-(3-(methylsulphanyl)propyl)-1H-indol-3-yl)(2,3-dichloro-phenyl)methanone; cannabinoid receptors (cb2); G proteins coupled receptors
02/19/2004US20040034055 For treating central nervous system disorders, immunomodulatory disorders, antimalaria, viral disease of Borna virus, Hepatitis; a 6-azatricyclo(6.3.1.01,6)dodecane derivatives
02/19/2004US20040034048 Didepsipeptide-based endoparasiticides, new didepsipeptides and process for preparing the same
02/19/2004US20040033996 Methods of preparing substituted tetracyclines with transition metal-based chemistries
02/19/2004US20040033995 Nitrogen compounds, stereoisomers and/or racemic mixtures used as enzyme inhibitors for prophylaxis of inflammatory diseases
02/19/2004US20040033986 Anti tubercular drug: compositions and methods
02/19/2004US20040033980 Method of down-regulating gene expression
02/19/2004CA2495518A1 Bicyclic heteroaromatic compounds as kinase inhibitors
02/19/2004CA2494865A1 Electrospun amorphous pharmaceutical compositions
02/19/2004CA2494258A1 The use of fermented wheat-germ in the feeding and veterinary practice
02/18/2004EP1389103A2 Synthesis and evaluation of novel phthalimide mimics as anti-angiogenic agents
02/18/2004EP1233952B1 Pesticidal n-heteroaryl alpha-alkoximino-carboxamides
02/18/2004EP1233786B1 Product comprising at least a no synthase inhibiting substance associated with at least a phospholipase a2 inhibiting substance for the preparation of a medicament
02/18/2004EP1178958B1 N-cyanomethyl amides as protease inhibitors
02/18/2004EP1163256B1 Hemihydrate of 16.alpha.-bromoepiandrosterone
02/18/2004EP0863765B1 Pharmaceutical compositions of cyclosporine with a polyethoxylated saturated hydroxy-fatty acid
02/18/2004CN1476437A Nematicidal trifluorobutenes
02/18/2004CN1476432A Indole and dihydroindole derivatives
02/18/2004CN1476430A Delta 1-pyrrolines used as pesticides
02/17/2004US6693132 Methods for using alkanoyloxymethyl esters
02/17/2004US6693113 As immunomodulators and for inducing cytokine biosynthesis in animals, for therapy of viral infections
02/17/2004CA2293823C 4"-substituted-9-deoxo-9a-aza-9a-homoerythromycin a derivatives
02/17/2004CA2074348C Stable compositions for parenteral administration and their use